1. Home
  2. QLGN vs TGL Comparison

QLGN vs TGL Comparison

Compare QLGN & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • TGL
  • Stock Information
  • Founded
  • QLGN 1996
  • TGL 2020
  • Country
  • QLGN United States
  • TGL United States
  • Employees
  • QLGN N/A
  • TGL N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • TGL Retail: Computer Software & Peripheral Equipment
  • Sector
  • QLGN Health Care
  • TGL Technology
  • Exchange
  • QLGN Nasdaq
  • TGL Nasdaq
  • Market Cap
  • QLGN 4.8M
  • TGL 4.1M
  • IPO Year
  • QLGN N/A
  • TGL 2022
  • Fundamental
  • Price
  • QLGN $5.02
  • TGL $1.08
  • Analyst Decision
  • QLGN
  • TGL
  • Analyst Count
  • QLGN 0
  • TGL 0
  • Target Price
  • QLGN N/A
  • TGL N/A
  • AVG Volume (30 Days)
  • QLGN 4.8M
  • TGL 5.8M
  • Earning Date
  • QLGN 11-13-2025
  • TGL 11-13-2025
  • Dividend Yield
  • QLGN N/A
  • TGL N/A
  • EPS Growth
  • QLGN N/A
  • TGL N/A
  • EPS
  • QLGN N/A
  • TGL N/A
  • Revenue
  • QLGN N/A
  • TGL $1,468,790.00
  • Revenue This Year
  • QLGN N/A
  • TGL N/A
  • Revenue Next Year
  • QLGN N/A
  • TGL N/A
  • P/E Ratio
  • QLGN N/A
  • TGL N/A
  • Revenue Growth
  • QLGN N/A
  • TGL N/A
  • 52 Week Low
  • QLGN $1.61
  • TGL $0.70
  • 52 Week High
  • QLGN $10.45
  • TGL $61.50
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 61.57
  • TGL 46.32
  • Support Level
  • QLGN $4.91
  • TGL $1.05
  • Resistance Level
  • QLGN $6.16
  • TGL $1.23
  • Average True Range (ATR)
  • QLGN 1.00
  • TGL 0.10
  • MACD
  • QLGN 0.06
  • TGL -0.00
  • Stochastic Oscillator
  • QLGN 43.01
  • TGL 12.66

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.

Share on Social Networks: